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Abstract
Background: Device optimization is not routinely performed in patients who underwent 
cardiac resynchronization therapy (CRT) device implantation. Noninvasive optimization of 
CRT devices by measurement of cardiac output (CO) can be used as a simple method to assess 
ventricular systolic performance. The aim of this study was to assess whether optimization of 
atrioventricular (AV) and interventricular (VV) delay can improve hemodynamic response to 
CRT and whether this optimization should be performed for each patient individually.
Methods: Twenty patients with advanced heart failure New York Heart Association (NYHA) 
class III/IV, left ventricular ejection fraction ≤ 35% and left bundle branch block (QRS ≥ 120 ms) 
in sinus rhythm were evaluated from 24 h to 48 h after implantation of a CRT device by means 
of impedance cardiography (ICG). CO was fi rst measured at each patient’s intrinsic rhythm. 
Patients then underwent adjustments of AV and VV delay from 80 ms to 140 ms and from 
–60 ms to +60 ms, respectively in 20 ms increment steps and CO at each setting was measured 
by ICG. Both AV and VV delays were programmed according to the greatest improvement in 
CO compared to intrinsic rhythm.
Results: There was a statistically signifi cant increase in CO measured at the intrinsic rhythm 
compared to different AV delay by mean of 21% (3.8 ± 1.0 vs. 4.6 ± 0.1 L/min, p < 0.05). 
Optimal AV/VV delays with left ventricle-preexcitation or simultaneous biventricular pacing 
caused additional increased CO from intrinsic rhythm by mean of 32.6% (3.8 ± 1.0 vs. 5.04 ± 
± 1.0 L/min, p < 0.05). Optimal AV/VV setting delays also resulted in improved hemodynamic 
responses compared to VV factory setting delay.
Conclusions: Both AV and VV delay optimization should be performed in clinical practice. 
Optimal AV delay improved outcome. However, combination of optimized AV/VV delays provi-
ded the best hemodynamic response. Optimized AV/VV delays with left ventricle-preexcitation 
or simultaneous biventricular pacing increased hemodynamic output compared to intrinsic 
rhythm and VV factory setting delay. (Cardiol J 2013; 20, 4: 411–417)
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Introduction
Cardiac resynchronization therapy (CRT) is 
an important therapeutic option for patients with 
advanced heart failure (when optimal pharmacothe-
rapy is insuffi cient) [1]. The essence of CRT is to 
increase cardiac output (CO), reducing interventri-
cular (VV) conduction delay caused by left bundle 
branch block [2]. CRT reduces clinical symptoms 
of heart failure, decreasing incidence of hospitaliza-
tion, and also signifi cantly decreasing mortality in 
these patients [3, 4]. The success of CRT depends 
on many factors such as appropriate location of the 
left ventricular (LV) electrode, and optimal timing of 
atrioventricular (AV) and VV delays [5, 6]. Optimal 
programming of AV and VV delays plays an impor-
tant role in reducing the proportion of patients who 
derive no apparent benefi t from CRT (the so called 
“non-responders”), despite correct positioning of 
the LV electrode [7]. Timing of optimal AV and VV 
conduction differs among patients and requires in-
dividual settings. The most common non-invasive 
methods used in optimization of CRT settings are 
echocardiography and impedance cardiography 
(ICG).The purpose of this study was to see whether 
optimization of AV and VV delays by ICG contributes 
to improvement of hemodynamic response to CRT 
and whether this optimization should be performed 
for each patient individually.
Methods
Patient characteristics
The study included 20 patients with advan-
ced heart failure, scheduled for implanting a CRT 
device. All the patients were of New York Heart 
Association (NYHA) class III heart failure, de-
spite appropriate medical therapy, with impaired 
LV ejection fraction (LVEF) £ 35%, wide QRS 
due to left bundle branch block (QRS duration 
≥ 120 ms) and sinus rhythm on 12-lead surface 
electrocardiography. For all the patients echo-
cardiography was performed, measurements of 
LV dimensions, LVEF, extent of interventricular 
mechanical dyssynchrony, and evaluation for val-
ve disease, particularly mitral regurgitation were 
obtained. All the patients were receiving optimal 
medical treatment. Baseline characteristics of the 
study patients are detailed in Table 1.
The present study was approved by the Insti-
tutional Review Board of the Medical University 
of Lodz. The study protocol was approved by the 
local Ethics Committee, and informed consent was 
obtained from all the patients.
Implantation
A CRT defi brillator (CRT-D) was implanted in 
all patients except one who received a CRT pace-
maker (CRT-P). The implantation was performed 
according to routine procedure in all patients. 
The LV lead was positioned via the over-the-wire 
technique in the coronary sinus vein branch that 
was the easiest. Next impedance measurements 
were performed in this position by ICG. We then 
positioned the LV lead at 2 to 4 different sites, 
depending on the anatomy of the coronary sinus 
vein branches. Hemodynamic measurements were 
obtained at each site, in order to obtain the best 
response. The right atrial lead was implanted in 
the right atrial appendage and fi nally the right 
ventricular (RV) lead was placed in the midseptum 
or RV apex according to operator preference. For 
all patients the device was programmed in DDD 
mode with a lower pacing rate at 40 bpm  to 50 bpm 
to ensure continuous atrial synchronous biven-
tricular tracking of the intrinsic sinus rhythm [8]. 
The AV delay was set at 120 ms as a standard value 
[9], with VV delay set at 0 ms (VV factory setting 
delay). These parameters were unchanged until 
optimization.
Table 1. Patients’ characteristics.
Characteristic Value (total 
cohort: n = 20)
Age [years] 66.9 ± 7.6 
(range 55–78)
Gender (female/male) 2/18
Etiology
Nonischemic 7 (35%) 
QRS [ms] 176 ± 27 
(range 120–220) 
PQ [ms] 172 ± 31
LVEDV [mL] 251 ± 71
LVESV [mL] 186 ± 62
LVEF [%] 25 ± 4.7 
(range 19–35) 
VV mechanical delay [ms] 50 ± 30
NYHA class III 20 (100%)
ACEI 19 (95%)
Beta-blockers 17 (85%)
Spironolactone 11 (55%)
Loop diuretics 20 (100%)
LVEDV — left ventricular end-diastolic volume; LVESV — left 
ventricular end-systolic volume; LVEF — left ventricular ejec-
tion fraction; VV — intraventricular; NYHA — New York Heart 
Association; ACEI — angiotensin converting enzyme inhibitor; 
beta-blockers — beta-adrenergic receptor blockers
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Impedance cardiography
ICG was performed with a commercial non-
invasive continuous CO system (CardioScreen; 
Medizinische Messtechnik GmbH, Ilmenau, 
Germany) used for noninvasive hemodynamic 
measurements and monitoring of hemodynamic 
parameters.
Changes in volume and velocity of blood in 
the aorta cause variations in the thoracic bio-
-impedance which is measured and displayed as the 
ICG waveform. With each cardiac cycle, thoracic 
fl uid volume changes, which affects the impedance 
to the electrical signal transmitted by the sensors. 
This signal is applied to the innovative Physiologi-
cal Adaptive Signal Analysis algorithm to provide 
key hemodynamic parameters noninvasively and 
continuously [10]. The ICG system was composed 
of a high-frequency (85 kHz) sine wave generator 
with 4 dual electrodes placed on either side of the 
body, which allowed for noninvasive measurement 
of CO and other hemodynamic parameters calcula-
ted on a beat-to-beat basis from the transthoracic 
impedance signal.
Optimization protocol
Device settings were optimized within 24 h to 
48 h after CRT device implant via ICG. Patients 
were examined in the supine position in a silent 
room to reduce the impact of sympathetic activa-
tion by external stimuli. Before optimization each 
patient rested for a period of stabilization and 
equilibration (10 min) followed by AV and then VV 
delay optimization. The DDD mode, with a lower 
rate limit of 40 bpm to avoid effects of atrial pa-
cing on the AV interval, was programmed for each 
patient [8]. Telemetry between the CRT device 
and the programmer was disconnected during data 
acquisition, at each parameter setting, to avoid 
interference. The period for each AV and VV delay 
setting was preceded by a stabilization period of 
1 min and at each stage measurements were made 
4 times, with 20 cycles of beat for each reading and 
the average of all readings was calculated. The 
fi rst stage of the optimization protocol was the CO 
measurement with each patient’s intrinsic rhythm. 
With the VV fi xed at 0 ms, AV delay optimization 
was then adjusted from 80 ms to 140 ms in 20 ms 
increment steps and the CO was registered. AV 
delay values longer than 140 ms were not analyzed 
because of correct native AV conduction. The AV 
delay was set according to the largest CO (optimal 
AV delay). Next, with the optimized AV delay, opti-
mal VV delay was estimated, and CO at each setting 
was measured (AV/VV delays). The VV delays were 
adjusted in 20 ms intervals through a set from 
LV-preexcitation by –60 ms to RV-preexcitation 
by +60 ms, according to the previously published 
methods [11]. The optimal device setting was 
a combination of AV and VV delays providing the 
largest CO (optimal AV/VV delays). In addition, CO 
at the VV factory setting delay was compared to 
intrinsic rhythm and optimal AV/VV delays.
Statistical analysis
Statistical analyses were performed with 
STATISTICA PL 9.0 software. Numerical variables 
are presented as mean ± standard deviation (SD). 
For categorical variables the number of obser-
vations (n) and percentage (%) are presented. 
Normality was tested with the t test for dependent 
samples and the Shapiro-Wilk  test for normality. 
Analysis of variance (ANOVA) with repeated me-
asures and post-hoc analysis was used to compare 
numerical variables. Results were considered 
statistically signifi cant for p < 0.05.
Results
Lead placement
The individual best hemodynamic response 
for each patient was associated with midlateral 
placement of the LV lead in 9 patients, apicolateral 
placement in 4 patients, basolateral placement in 
3 patients, apicoposterior placement in 2 patients 
and basal-anterior and basal-posterior placement 
in 1 patient. The RV lead was positioned at RV 
apex in 14 (70%) patients and at RV midseptum in 
6 (30%) patients.
Setting of optimal AV and VV delays
Using the noninvasive continuous CO system 
an optimal AV delay setting of 80 ms was measured 
for 1 (5%) patient, 100 ms for 6 (30%) patients, 
120 ms for 7 (35%) patients and 140 ms for 6 (30%) 
patients. The mean optimal AV delay value was 
118 ± 18 ms. The most common optimal VV delay 
value was programmed with simultaneous biventri-
cular pacing (0 ms) for 9 (45%) patients, and with 
preexcitation of LV pacing by –40 ms for 7 (35%) 
patients, by –60 ms for 3 (15%) patients and by 
–20 ms for 1 (5%) patient. There were no patients 
with RV preexcitation. The mean optimal VV delay 
was –23 ± 23 ms. Programmed settings for optimal 
AV and VV delays are shown in Figure 1.
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Outcome of noninvasive CO measured with 
optimal AV and VV delay settings
The CO value obtained at intrinsic rhythm 
was 3.8 ± 1.0 L/min. The CO obtained at intrinsic 
rhythm compared with the different AV delay was 
increased by 21% (3.8 ± 1.0 vs. 4.6 ± 0.1 L/min, 
p < 0.05). The largest CO (4.7 L/min, increase of 
23% when compared to intrinsic rhythm, p < 0.05) 
was achieved when AV delay was set at 120 ms 
(Fig. 2).
There was a signifi cant increase in CO with all 
AV delays compared to CO measured at intrinsic 
rhythm. No signifi cant differences were observed 
between CO values measured with different AV 
delays (Table 2).
With different AV/VV delays optimization CO 
improved from intrinsic rhythm by 18.4% (3.8 ± 
± 1.0 vs. 4.5 ± 0.2 L/min, p < 0.05). The lar-
gest improvement in CO of 24.4% (3.8 ± 1.0 vs. 
4.7 ± 0.9, p < 0.05 L/min) was obtained with AV/VV 
delays set up at simultaneous biventricular pacing 
(Fig. 3). There was a signifi cant increase in CO for 
all VV delays compared to CO at intrinsic rhythm. 
Pacing with LV preexcitation by –60 ms and by 
–40 ms showed signifi cant differences in CO com-
pared to RV preexcitation (Table 3).
The mean optimal AV/VV delays resulted in 
an increase of CO from baseline by 32.6% (3.8 ± 
± 1.0 vs. 5.04 ± 1.0 L/min, p < 0.05). In additional 
Table 2. Statistical value for cardiac output with different AV delay settings.
Variable (CO/AV) Intrinsic rhythm 80 ms 100 ms 120 ms 140 ms
Intrinsic rhythm x p < 0.05 p < 0.05 p < 0.05 p < 0.05
80 ms p < 0.05 x 1.000* 0.514* 0.910*
100 ms p < 0.05 1.000* x 0.537* 0.921*
120 ms p < 0.05 0.514* 0.537* x 0.951*
140 ms p < 0.05 0.910* 0.921* 0.951* x
CO — cardiac output; AV —  atrioventricular delay; *p value not significant
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Figure 1. The frequency of different settings of optimal AV and VV delays.
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Figure 2. The effect on cardiac output in different AV 
delay settings.
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CO during pacing with the VV factory setting delay 
was lower compared to mean optimal AV/VV delays 
by 7.2% (4.7 ± 0.9 vs. 5.04 ± 1.0 L/min, p < 0.05). 
A comparison of CO at intrinsic rhythm with the 
VV factory setting delay, and with optimal AV/VV 
delay settings is shown in Figure 4.
There was no signifi cant difference in heart rate 
during CO estimated at baseline (69 ± 7.5 bpm), 
with AV delay optimization (70 ± 5.3 bpm), 
with the VV delay factory setting (70 ± 2.5 bpm) 
or with AV/VV delay optimization (69.4 ± 7 bpm, 
p > 0.05).
Discussion
Invasive monitoring of hemodynamics in he-
art failure has been the gold standard, but it still 
Figure 4. Comparison of cardiac output changes in in-
trinsic rhythm, VV factory setting and optimal AV/VV 
delays.
Table 3. Statistical value of cardiac output with different AV/VV delay settings.
Variable (CO/VV) Intrinsic 
rhythm
–60 ms –40 ms –20 ms 0 ms 20 ms 40 ms 60 ms
Intrinsic rhythm p < 0.05 p < 0.05 p < 0.05 p < 0.05 p < 0.05 p < 0.05 p < 0.05
–60 ms 1.000* 0.598* 1.000* 0.299* p < 0.05 p < 0.05
–40 ms 0.598* 1.000* 0.299* p < 0.05 p < 0.05
–20 ms 0.410* 0.999* 0.935* 0.848*
0 ms 0.169* p < 0.05 p < 0.05
20 ms 0.996* 0.979*
40 ms 1.000*
60 ms
CO — cardiac output; AV — atrioventricular delay; *p value not significant
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carries signifi cant associated risks. Recent studies 
have described the use of ICG to guide the opti-
mal setting of CRT devices. Use of this technique 
has resulted in signifi cant improvements in CO, 
owing to adjustment of both AV and VV delays [10, 
11]. Result of the present study confi rmed that 
noninvasive ICG is a useful and reliable method 
for optimizing AV and VV delays. There were 
signifi cant variations in the optimal CRT timing 
settings between patients. Therefore, to achieve 
benefi t from CRT, it is necessary to optimize each 
patient’s device individually not to use “universal” 
settings for all. The present results demonstrated 
that individual adjustment of AV and VV delays, 
compared to intrinsic rhythm, resulted in hemody-
namic improvements. An individually based appro-
ach to the largest CO was associated with different 
AV delays and VV delays with LV preexcitation or 
simultaneous biventricular pacing.
AV delay
The setting of AV delay for individual pa-
tients measured by echocardiography allows for 
electromechanical synchrony of atrial and ventri-
cular contractions. In addition, it improves cardiac 
contractile function and therefore improves long-
-term prognosis [12]. As a quick and consistent 
measurement, CO is the most frequently used 
hemodynamic parameter for fi nding an optimal AV 
delay. Early studies have shown that compared to 
the factory setting a properly adjusted AV delay 
can contribute to CO increases up to 40% [13]. The 
development of ICG has provided the opportunity 
to measure CO noninvasively in contrast to previo-
us invasive techniques. Results received with ICG 
correlate closely with those of invasive techniques 
[14, 15]. Studies have also demonstrated that op-
timization of AV delay by ICG is a useful and less 
expensive alternative to echocardiography during 
standard dual chamber pacing [16, 17]. Another stu-
dy demonstrated that ICG can be used to determine 
CO during LV pacing at various AV intervals, with 
strong correlation to results obtained by Doppler 
echocardiography [18]. In addition, hemodyna-
mic benefi ts of optimization required individual 
adjustment of AV delay. Our present results are 
consistent with these observations.
VV delay
Apart from benefi ts of AV delay manipulation, 
modifi cation of VV delay might also improve the 
hemodynamic response to CRT. Some invasive 
studies assessing the hemodynamic response 
to VV programming have demonstrated that se-
quential biventricular pacing is more effective 
than simultaneous biventricular pacing [19, 20]. 
Similar fi ndings were reported by Marsan et al. 
[21]. They optimized sequential biventricular 
pacing which, increased LV systolic performance 
(EF and LV outfl ow-tract- velocity-time-integral) 
compared to simultaneous stimulation estimated 
by noninvasive Doppler echocardiography. Other 
noninvasive studies have confi rmed that a better 
effect on hemodynamic response in CRT is ob-
tained with both AV and VV delays as verifi ed by 
3-dimensional echocardiography [22], radionuclide 
ventriculography [23], fi nger plethysmography [24] 
and recently, ICG [10, 11, 25]. Comparing optimiza-
tion techniques, echocardiographic methods yield 
statistically insignifi cant data in the majority of 
patients (62–82%) whereas ICG yields statistically 
signifi cant results in 84% and 75% of patients for 
AV and VV interval optimization respectively [26]. 
It seems that ICG is free of some of the limitations 
of echocardiography. It is noninvasive, replicable, 
undemanding of qualified personnel, and less 
expensive than echocardiography [16]. In clinical 
practice, individual adjustment of VV delay is often 
ignored [27]. This might be due to the fact that VV 
delay optimization based on echocardiography is 
a relatively time-consuming procedure.
With a considerable growth in CRT implant, 
it will be impossible to optimize devices echocar-
diographically in all patients [28]. The study of 
Bogaard and associates reported that the optimal 
VV delay is –30 ms (–60 ms to 5 ms) and –20 ms 
(–40 ms to 0 ms) at non-optimal and optimal LV 
lead sites, respectively [29]. Heinroth and asso-
ciates compared VV delays and reported that LV 
preexcitation by 40 ms resulted the largest mean 
CO, and similar values were obtained with LV pre-
excitation by 20 ms and 60 ms [10]. The optimal 
pacing set-up varied greatly from patient to patient. 
In present study, optimization of both AV and VV 
delays by ICG turned out simply and easy method, 
confi rming the effi cacy of CRT setting optimization. 
The greatest benefi t for patients with individually 
optimized AV delay were obtained with VV delay 
and LV preexcitation by –60 ms and by –40 ms; 
the mean optimal VV delay with improvement 
hemodynamic response was –23 ± 23 ms. Optimal 
settings differed from patient to patient.
Limitations of the study
The present study was based on a small non-
randomized population. According to the fact that 
there are studies reporting that optimal AV delay 
values during rest or exercise do not differ signi-
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fi cantly [30], we performed AV and VV optimiza-
tion with patients in the supine position at rest. 
Nonetheless, it would be worthwhile to assess AV 
and VV delays under other conditions, for example 
during normal daily activity or exercise [30]. Finally 
our optimization protocol was based on previous 
study [11]. We optimized AV delays during simulta-
neous biventricular pacing and then optimized VV 
delays according to the optimal AV delay.
Conclusions
Both AV and VV delay optimization should be 
performed in clinical practice. Echocardiographic 
techniques, despite being time-consuming, de-
liver practical information. However, it appears 
that other methods of assessment might also be 
benefi cial. AV and VV delay optimization by ICG is 
a valuable method and an interesting alterative. Op-
timal AV delay improved CO in the present study. 
However, combination of optimized AV/VV delays 
provided the best hemodynamic response. Com-
pared to intrinsic rhythm and VV factory setting 
delay optimal AV/VV delays with LV-preexcitation 
and simultaneous biventricular pacing increased 
hemodynamic output. The ICG is a useful noninva-
sive technique for optimization of CRT.
Confl ict of interest: none declared
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